These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34193468)

  • 21. Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
    Tincopa MA; Lyden A; Wong J; Jackson EA; Richardson C; Lok AS
    Dig Dis Sci; 2022 Feb; 67(2):481-491. PubMed ID: 33939147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
    Gracen L; Hayward KL; Aikebuse M; Williams S; Russell A; O'Beirne J; Powell EE; Valery PC
    Diabet Med; 2022 Jun; 39(6):e14799. PubMed ID: 35100462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study.
    Pfirrmann D; Huber Y; Schattenberg JM; Simon P
    J Med Internet Res; 2019 Jan; 21(1):e11250. PubMed ID: 30602434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.
    Komolafe O; Buzzetti E; Linden A; Best LM; Madden AM; Roberts D; Chase TJ; Fritche D; Freeman SC; Cooper NJ; Sutton AJ; Milne EJ; Wright K; Pavlov CS; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013157. PubMed ID: 34280304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients.
    Zelber-Sagi S; Bord S; Dror-Lavi G; Smith ML; Towne SD; Buch A; Webb M; Yeshua H; Nimer A; Shibolet O
    World J Gastroenterol; 2017 Mar; 23(10):1881-1890. PubMed ID: 28348495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parental perceptions regarding lifestyle interventions for obese children and adolescents with nonalcoholic fatty liver disease.
    Iñiguez IR; Yap J; Mager DR
    Paediatr Child Health; 2014 May; 19(5):e24-9. PubMed ID: 24855432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parental perceptions regarding lifestyle interventions for obese children and adolescents with nonalcoholic fatty liver disease.
    Iñiguez IR; Yap J; Mager D
    Paediatr Child Health; 2014 May; 19(5):236. PubMed ID: 24855423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China].
    Liang QF; Wang YD; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):760-765. PubMed ID: 29108205
    [No Abstract]   [Full Text] [Related]  

  • 30. Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Carneros D; López-Lluch G; Bustos M
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33198247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Katsagoni CN; Papachristou E; Sidossis A; Sidossis L
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32961669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
    Stavropoulos K; Imprialos K; Pittaras A; Faselis C; Narayan P; Kokkinos P
    Curr Vasc Pharmacol; 2018; 16(3):239-245. PubMed ID: 28637408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How Do Orthopaedic Providers Conceptualize Good Patient Outcomes and Their Barriers and Facilitators After Acute Injury? A Qualitative Study.
    Doorley JD; Fishbein NS; Greenberg J; Reichman M; Briskin EA; Bakhshaie J; Vranceanu AM
    Clin Orthop Relat Res; 2023 Jun; 481(6):1088-1100. PubMed ID: 36346734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet and physical activity after liver transplant: A qualitative study of barriers and facilitators to following advice.
    Spillman LN; Melville-Claxton A; Gatiss GA; Fernandez N; Madden AM
    J Hum Nutr Diet; 2021 Oct; 34(5):910-919. PubMed ID: 33646641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of web-based interventions on non-alcoholic fatty liver disease (NAFLD) in obese children: A study protocol for a randomized controlled trial.
    Tian C; Xu J; Wang G; Yu L; Tang X
    Front Public Health; 2022; 10():930901. PubMed ID: 36339187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living in the non-alcoholic fatty liver disease silent epidemic: a qualitative systematic review of patients' perspectives.
    Ng CH; Lim WH; Chin YH; Yong JN; Zeng RW; Chan KE; Tan DJH; Fu CE; Tang ASP; Goh LH; Devi K; Chew NWS; Mak LL; Tamaki N; Huang DQ; Noureddin M; Siddiqui MS; Loomba R; Sanyal AJ; Muthiah M
    Aliment Pharmacol Ther; 2022 Aug; 56(4):570-579. PubMed ID: 35791632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China.
    Zhang W; Chao S; Chen S; Rao H; Huang R; Wei L; Lok AS
    Dig Dis Sci; 2019 Mar; 64(3):708-717. PubMed ID: 30483909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of NAFLD with diet, physical activity and exercise.
    Romero-Gómez M; Zelber-Sagi S; Trenell M
    J Hepatol; 2017 Oct; 67(4):829-846. PubMed ID: 28545937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted mass media interventions promoting healthy behaviours to reduce risk of non-communicable diseases in adult, ethnic minorities.
    Mosdøl A; Lidal IB; Straumann GH; Vist GE
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011683. PubMed ID: 28211056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis.
    Utz-Melere M; Targa-Ferreira C; Lessa-Horta B; Epifanio M; Mouzaki M; Mattos AA
    Ann Hepatol; 2018; 17(3):345-354. PubMed ID: 29735796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.